Delivery Device Continues To Be Intarcia’s Downfall Ahead Of FDA Panel On Nonapproval of Implantable GLP-1

 
• By Sarah Karlin-Smith
  
delivery driver on scooter
Mode of delivery was meant to be a selling point but instead is one of Intarcia’s ITCA 650’s biggest challenges to FDA approval • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from United States

More from North America